6 terminated. 6 Phase 2, 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Terminated 6 |
| Phase 3 | 2 | Terminated 2 |
| Phase 1 | 1 | Terminated 1 |
Follow Lucentis: new trials by email Literature Review of Lucentis trials Research Report on Lucentis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety Study of Zimura in Combination With Anti-VEGF Therapy in Patients With Neovascular AMD Avacincaptad Pegol, Avastin, Lucentis - Neovascular Age-Related Macular Degeneration | Phase 2 | Terminated | IVERIC bio, Inc. | 1 | 2016-10-20 | 2025-03-13 |
| Clinical Assessment Of Age-related Macular Degeneration Patients After Early Diagnosis and Treatment With Ranibizumab ranibizumab - Age-Related Macular Degeneration | Phase 2 / Phase 3 | Terminated | University of California, San Diego | 20 | 2011-07-01 | 2019-08-28 |
| A Study of Intravitreal Injections of 2.0mg Ranibizumab in Subjects With Chronic Fluid On OCT Post Multiple Injections With Ranibizumab (Super-dose Anti-VEgf SAVE Trial) Ranibizumab - Age Related Macular Degeneration, Choroidal Neovascular Membrane | Phase 1 / Phase 2 | Terminated | David M. Brown, M.D. | 88 | 2009-12-01 | 2017-01-02 |
| Phase 2 Study of an Ocular Sirolimus (Rapamycin) Formulation in Combination With Lucentis® in Patients With Age-Related Macular Degeneration Sirolimus in combination with ranibizumab, Placebo in combination with ranibizumab - Age-Related Macular Degeneration, Choroidal Neovascularization | Phase 2 | Terminated | Santen Inc. | 62 | 2008-12-01 | 2013-01-10 |
| Verteporfin Photodynamic Therapy Administered in Conjunction With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD) Verteporfin Photodynamic Therapy, Ranibizumab, Placebo - Macular Degeneration, Choroidal Neovascularization | Phase 2 / Phase 3 | Terminated | Novartis | 255 | 2007-05-01 | 2011-04-21 |
| Intravitreal Ranibizumab to Treat Macular Edema After Panretinal Photocoagulation (Phase II) ranibizumab - Proliferative Diabetic Retinopathy, Macular Edema | Phase 2 | Terminated | Jumper, J. Michael, M.D. | 6 | 2007-03-01 | 2019-03-05 |
Macular Degeneration (4) · Choroidal Neovascularization (3) · Eye Diseases (1) · Macular Edema (1) · Retinal Degeneration (1) · Retinal Diseases (1)
David M. Brown, M.D. (1) · IVERIC bio, Inc. (1) · Jumper, J. Michael, M.D. (1) · Novartis (1) · Santen Inc. (1) · University of California, San Diego (1)
United States (4) · Austria (1) · Belgium (1) · Denmark (1) · France (1) · Germany (1) · Hungary (1) · Italy (1) · Netherlands (1) · Poland (1) · Spain (1) · Switzerland (1) · United Kingdom (1)
David M Brown, MD (1) · Henry Ferreyra, MD (1) · J. Michael Jumper, M.D. (1) · Joel Naor, MD (1)